Why Novo Nordisk’s Drugs Are Anti-Obesity Game-Changers: CNBC Healthy Returns Summit 2023
HTML-код
- Опубликовано: 25 авг 2024
- Lars Fruergaard Jørgensen, Novo Nordisk A/S President & CEO
Karin Conde-Knape, Novo Nordisk Senior Vice President for Global Drug Discovery
Moderator: Meg Tirrell, CNBC Senior Health & Science Reporter
More from the CNBC Events: bit.ly/40ZdNd1
Subscribe to the CNBC Events Marketing Newsletter here: cnb.cx/3nJqzht
Follow on Twitter: / cnbcevents
Follow on LinkedIn: / cnbcevents
#CNBC #healthcare
I thought Meg left CNBC